CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $250.8M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 2.74: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.01%Above 5Y avg (2.52%)
Annual Rate
JPY 40.00Paid semi-annual
Payout Ratio
37.2%Sustainable
Next Ex-Dividend
Nov 27, 2026
The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2026, balance sheet FY2025, cash-flow statement FY2025. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
39.34BJPY250.80M · vs all stocks (USD)
Trailing P/E
12.41xRevenue (TTM)
50.65BJPY322.89M · vs all stocks (USD)
Profit Margin
6.24%Beta
0.1990xvs all stocks
52-Week Change
8.64%vs all stocks
Forward Annual Dividend Yield
3.01%vs all stocks
Market Capitalization
39.34BJPY250.80M · vs all stocks (USD)
Enterprise Value
46.06BJPY293.60M · vs all stocks (USD)
Trailing P/E
12.41xForward P/E
6.18xPEG Ratio
-0.2328xPrice to Sales (TTM)
0.7437xPrice to Book (MRQ)
0.7244xEnterprise to Revenue
0.9090xEnterprise to EBITDA
5.74xProfit Margin
6.24%Operating Margin
6.35%Return on Assets (TTM)
3.00%Return on Equity (TTM)
5.97%Revenue (TTM)
50.65BJPY322.89M · vs all stocks (USD)
Revenue per Share (TTM)
1.72KJPYUpdated Sep 21, 2026Quarterly Revenue Growth
-0.80%Gross Profit (TTM)
9.90BJPY63.09M · vs all stocks (USD)
EBITDA (TTM)
8.25BJPY52.60M · vs all stocks (USD)
Net Income (TTM)
3.16BJPY20.15M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
29.40%Operating Cash Flow (TTM)
9.38BJPY59.78M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.30BJPY14.69M · vs all stocks (USD)
Forward Annual Dividend Rate
40.00JPYUpdated Sep 21, 2026Forward Annual Dividend Yield
3.01%vs all stocks
Trailing Annual Dividend Rate
40.00JPYUpdated Sep 21, 2026Trailing Annual Dividend Yield
3.01%vs all stocks
5-Year Average Dividend Yield
2.52%vs all stocks
Payout Ratio
37.21%Minority Interest (Equity)
64.00MJPYFY2025 · May 31, 2025EPS (Basic)
107.49JPYFY2026 · May 31, 2026EPS (Diluted)
107.49JPYFY2026 · May 31, 2026Basic Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Diluted Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Operating Cash Flow
2.57BJPYFY2025 · May 31, 2025Free Cash Flow
-4.22BJPYFY2025 · May 31, 2025Cash & Cash Equivalents (End of Period)
2.21BJPYFY2025 · May 31, 2025Starting Profit (CF Statement)
2.96BJPYFY2025 · May 31, 2025Other Non-cash Items
2.09BJPYFY2025 · May 31, 2025Change in Accounts Receivable (CF)
-4.89BJPYFY2025 · May 31, 2025Change in Other Assets/Liabilities
2.42BJPYFY2025 · May 31, 2025Capital Expenditures
-6.79BJPYFY2025 · May 31, 2025Net Intangibles (CF)
-241.00MJPYFY2025 · May 31, 2025Net Acquisitions
-707.00MJPYFY2025 · May 31, 2025Purchase of Investments
-6.00MJPYFY2025 · May 31, 2025Sale of Investments
444.00MJPYFY2025 · May 31, 2025Other Investing Activity
-66.00MJPYFY2025 · May 31, 2025Net Investing Cash Flow
-7.12BJPYFY2025 · May 31, 2025Long-term Debt Issuance
6.00BJPYFY2025 · May 31, 2025Long-term Debt Payments
-3.10BJPYFY2025 · May 31, 2025Common Stock Repurchase
-623.00MJPYFY2025 · May 31, 2025Common Dividends Paid
-998.00MJPYFY2025 · May 31, 2025Other Financing Charges
-2.00MJPYFY2025 · May 31, 2025Net Financing Cash Flow
1.28BJPYFY2025 · May 31, 2025Shares Outstanding
28.74MSharesUpdated Sep 21, 2026Float Shares
24.96MSharesUpdated Sep 21, 2026% Held by Insiders
15.44%vs all stocks
% Held by Institutions
32.79%vs all stocks
Total Cash (MRQ)
954.00MJPY6.08M · vs all stocks (USD)
Total Cash per Share (MRQ)
33.76JPYUpdated Sep 21, 2026Total Debt (MRQ)
9.29BJPY59.25M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1756xCurrent Ratio (MRQ)
2.62xBook Value per Share (MRQ)
1.84KJPYUpdated Sep 21, 2026Total Assets
78.00BJPY497.25M · vs all stocks (USD)
Total Current Assets
41.71BJPYFY2025 · May 31, 2025Total Liabilities
25.94BJPYFY2025 · May 31, 2025Total Non-current Assets
36.29BJPYFY2025 · May 31, 2025Total Non-current Liabilities
8.89BJPYFY2025 · May 31, 2025Total Current Liabilities
17.05BJPYFY2025 · May 31, 2025Cash & Cash Equivalents
2.21BJPYFY2025 · May 31, 2025Accounts Receivable
12.67BJPYFY2025 · May 31, 2025Inventory
18.41BJPYFY2025 · May 31, 2025Accounts Payable
4.68BJPYFY2025 · May 31, 2025Short-term Debt
3.46BJPYFY2025 · May 31, 2025Other Current Liabilities
4.48BJPYFY2025 · May 31, 2025Long-term Debt
8.43BJPYFY2025 · May 31, 2025Other Non-current Liabilities
224.00MJPYFY2025 · May 31, 2025Common Stock (Book)
7.19BJPYFY2025 · May 31, 2025Retained Earnings
37.18BJPYFY2025 · May 31, 2025Total Shareholders' Equity
52.07BJPY331.92M · vs all stocks (USD)
Treasury Stock
749.00MJPYFY2025 · May 31, 202552-Week Low
1.12KJPYUpdated Sep 21, 202652-Week High
1.52KJPYUpdated Sep 21, 202652-Week Change
8.64%vs all stocks
Beta
0.1990xvs all stocks
50-Day MA
1.30KJPYUpdated Sep 21, 2026200-Day MA
1.32KJPYUpdated Sep 21, 2026Avg 10-Day Volume
69.51KSharesUpdated Sep 21, 2026Avg 30-Day Volume
68.17KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
107.44JPYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.74: safe zoneNotable
Altman Z-Score: 2.74
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $250.8M, lower than 95% of all stocks globallySignificant
Market cap (USD): 250,799,856.407Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Acimmune SA
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Palisade Bio Inc.
Tier 1ProductionApproval-Gated PipelineRule
Akebia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Siga Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Seikagaku Corporation
Tier 1ProductionApproval-Gated PipelineRule